Windtree Therapeutics, Inc. (WINT)
OTCMKTS
· Delayed Price · Currency is USD
0.0245
+0.0015 (6.30%)
At close: Apr 29, 2026
Windtree Therapeutics Employees
Windtree Therapeutics had 14 employees as of December 31, 2024. The number of employees decreased by 6 or -30.00% compared to the previous year.
Employees
14
Change
-6
Growth
-30.00%
Revenue / Employee
n/a
Profits / Employee
-$3,487,929
Market Cap
1.03M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| LakeShore Biopharma | 573 |
| International Stem Cell | 33 |
| Evofem Biosciences | 29 |
| CERo Therapeutics Holdings | 8 |
| GB Sciences | 2 |
| Lyra Therapeutics | 27 |
| Iterum Therapeutics | 9 |
| Adaptimmune Therapeutics | 506 |
Windtree Therapeutics News
- 6 weeks ago - CommLoan Achieves Nationwide Regulatory Approval Across All 50 States - PRNewsWire
- 5 months ago - Windtree Therapeutics Announces It Will Receive $7.5 Million In Cash and Securities from the Recently Executed Termination Agreement with an Environmental Services Company - GlobeNewsWire
- 9 months ago - Windtree Announces Istaroxime has been Chosen for a Plenary Session Presentation at the Heart Failure Society of America 2025 - GlobeNewsWire
- 9 months ago - Windtree Therapeutics Announces Large Reduction of Preferred Series C and D Shares Outstanding by Conversion and Redemption - GlobeNewsWire
- 9 months ago - Windtree Therapeutics Announces Up To $520 Million in New Funding to Amplify BNB Cryptocurrency Treasury Strategy - GlobeNewsWire
- 10 months ago - Windtree To Launch BNB Crypto Treasury Strategy With Agreement For $60 Million Investment Led By Build And Build Corp. With Up To $140 Million More In Follow On Subscriptions - GlobeNewsWire
- 10 months ago - Windtree Announces Issuance of Istaroxime Patent for the United States for Acute Heart Failure - GlobeNewsWire
- 10 months ago - Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem's Hormone-Free, On-Demand Prescription Contraceptive Gel - GlobeNewsWire